• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Is Routine Preoperative Lab Testing Useful Prior to Urogynecologic Surgery?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Current preop guidelines (American Surgical Association) advise as follows
    • Routine hemoglobin/hematocrit and chemistry testing before surgery is not recommended | Should be reserved for certain preexisting conditions
  • However, approximately 90% of women undergoing benign gyn surgery undergo ≥1 such routine tests
  • Geynisman-Tan et al. (Female Pelvic Medicine & Reconstructive Surgery, 2020) sought to determine how often routine preoperative laboratory testing prior to urogynecologic surgery yielded useful meaningful results

METHODS:

  • Retrospective cohort study (2014 to 2017)
  • Participants
    • All reconstructive pelvic surgery cases
    • Major cases: Vaginal or laparoscopic apical prolapse repair with/without hysterectomy | Laparotomy | Fistula repair
    • Minor cases: Midurethral sling | Isolated colporrhaphy | Diverticulectomy | Sacral nerve stimulator implant
  • Study design
    • Women undergoing major surgery routinely had
      • A basic metabolic panel
      • Complete blood count (CBC), type, and screen
    • Women undergoing minor surgery had
      • Testing at the surgeon’s discretion
  • Meaningful abnormality definition
    • Hbg level <10 mg/dL | Plt count <100 x 103/mL | Creatinine level >1.0 mg/dL | Sodium level <135 mEq/L | Potassium level >3.6 mEq/L | Glucose level >200 mg/dL
  • If testing revealed a clinically meaningful abnormality, physician notes were reviewed to determine whether the abnormality
    • Was previously known
    • Led to surgical postponement

RESULTS:

  • 836 cases were reviewed
    • Major surgery: 49%
    • Minor surgery: 51%
    • Mean: 57 years
    • Mean BMI: 27 kg/m2
  • Comorbidities
    • Hypertension: 38%
    • Diabetes: 24%
    • Chronic kidney disease: 3%
    • Congestive heart failure: 4%
  • Preoperative Laboratory testing
    • CBC: 54%
    • Basic metabolic panel: 44%
  • Laboratory testing findings
    • New abnormalities identified on CBC: 6 women
      • All were Hgb between 8.0 and 10.0
    • Elevated creatine level (>1.0): 31 women
      • 90% of these cases had a history of hypertension
  • No surgeries were postponed or changed due to anemia, thrombocytopenia, or renal dysfunction
  • No clinically significant electrolyte abnormalities were identified
  • Type and screen were collected on 394 patients (47%)  
    • No patients were transfused intraoperatively
    • 1 patient received postoperative, nonemergent transfusion

CONCLUSION:

  • Routine preoperative laboratory testing for women undergoing urogynecologic surgery did not identify clinically meaningful abnormalities
  • Laboratory testing did not alter surgical management
  • The authors state

…urogynecologic surgeons in our department no longer order preoperative laboratory testing on any patients and defer all testing to the preanesthesia clinic

Type and screens are no longer ordered by the surgeons or anesthesiologists for urogynecologic patients

Learn More – Primary Sources:

Clinical Utility of Routine Preoperative Laboratory Assessment in a Urogynecologic Population

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Can Pain Following Gyn Oncology Surgery Be Managed with a Very Restrictive Opioid Protocol?
Which Surgeries are Most Likely to Lead to Urinary Tract Injury?
Surgery for Stress Urinary Incontinence: Which Procedures are Most Effective and Safest?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site